Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA.
Imaging Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Radiology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Neuroimage. 2017 Oct 1;159:32-45. doi: 10.1016/j.neuroimage.2017.07.021. Epub 2017 Jul 14.
Magnetic resonance spectroscopy (MRS) is the only biomedical imaging method that can noninvasively detect endogenous signals from the neurotransmitter γ-aminobutyric acid (GABA) in the human brain. Its increasing popularity has been aided by improvements in scanner hardware and acquisition methodology, as well as by broader access to pulse sequences that can selectively detect GABA, in particular J-difference spectral editing sequences. Nevertheless, implementations of GABA-edited MRS remain diverse across research sites, making comparisons between studies challenging. This large-scale multi-vendor, multi-site study seeks to better understand the factors that impact measurement outcomes of GABA-edited MRS. An international consortium of 24 research sites was formed. Data from 272 healthy adults were acquired on scanners from the three major MRI vendors and analyzed using the Gannet processing pipeline. MRS data were acquired in the medial parietal lobe with standard GABA+ and macromolecule- (MM-) suppressed GABA editing. The coefficient of variation across the entire cohort was 12% for GABA+ measurements and 28% for MM-suppressed GABA measurements. A multilevel analysis revealed that most of the variance (72%) in the GABA+ data was accounted for by differences between participants within-site, while site-level differences accounted for comparatively more variance (20%) than vendor-level differences (8%). For MM-suppressed GABA data, the variance was distributed equally between site- (50%) and participant-level (50%) differences. The findings show that GABA+ measurements exhibit strong agreement when implemented with a standard protocol. There is, however, increased variability for MM-suppressed GABA measurements that is attributed in part to differences in site-to-site data acquisition. This study's protocol establishes a framework for future methodological standardization of GABA-edited MRS, while the results provide valuable benchmarks for the MRS community.
磁共振波谱(MRS)是唯一一种能够无创地检测人脑内神经递质γ-氨基丁酸(GABA)内源性信号的生物医学成像方法。其在硬件和采集方法方面的改进,以及更广泛地使用能够选择性检测 GABA 的脉冲序列(特别是 J 差谱编辑序列),使其越来越受欢迎。然而,GABA 编辑 MRS 的实施在研究地点之间仍然存在差异,使得研究之间的比较具有挑战性。这项大规模的多供应商、多地点研究旨在更好地了解影响 GABA 编辑 MRS 测量结果的因素。成立了一个由 24 个研究地点组成的国际联盟。来自三大 MRI 供应商的扫描仪采集了 272 名健康成年人的数据,并使用 Gannet 处理管道进行了分析。MRS 数据是在中顶叶用标准的 GABA+和大分子(MM)抑制 GABA 编辑采集的。整个队列中 GABA+测量的变异系数为 12%,MM 抑制 GABA 测量的变异系数为 28%。多层次分析显示,GABA+数据的大部分方差(72%)归因于参与者在站点内的差异,而站点水平的差异比供应商水平的差异(8%)更能解释更多的方差(20%)。对于 MM 抑制 GABA 数据,方差在站点(50%)和参与者(50%)差异之间平均分布。研究结果表明,采用标准方案时,GABA+测量具有很强的一致性。然而,对于 MM 抑制 GABA 测量,由于站点间数据采集的差异,其可变性增加。本研究的方案为 GABA 编辑 MRS 的未来方法标准化建立了框架,同时为 MRS 社区提供了有价值的基准。